COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

Emmanuel Lamptey; Ephraim Kumi Senkyire; Dooshima Aki Benita; Evans Osei Boakye

doi:10.7774/cevr.2022.11.1.82

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

Clin Exp Vaccine Res. 2022 Jan;11(1):82-88. doi: 10.7774/cevr.2022.11.1.82. Epub 2022 Jan 31.

Authors

Emmanuel Lamptey¹, Ephraim Kumi Senkyire², Dooshima Aki Benita³, Evans Osei Boakye⁴

Affiliations

¹ Institute of Life and Earth Sciences (Including Health and Agriculture), Pan African University, University of Ibadan, Oyo, Nigeria.
² Ga-West Municipal Hospital, Ghana Health Service, Amasaman, Ghana.
³ Department of Psychology, Benue State University, Makurdi, Nigeria.
⁴ Department of Social Work, University of Ghana, Accra, Ghana.

Abstract

Following the development of the coronavirus disease 2019 (COVID-19) vaccines and the launching of vaccination, the World Health Organization has reported that the African Continent is lagging in the race to vaccinate its population against the deadly virus. The Continent has received a limited number of vaccines, implying that vaccine production needs to be scaled up in Africa. In this review, we summarize the current situation concerning COVID-19 vaccine development in Africa, progress made, challenges faced in vaccine development over the years and potential strategies that will harness vaccine production success.

Keywords: Africa; Barriers; COVID-19 vaccines; Development.

Publication types

Review